PreveCeutical Receives $616,802 AUD Research and Development Tax Incentive Cash Refund Cannabis Investing News
BriaCell Doses First Patient in Phase I/IIa Study Evaluating Bria-IMT™ in Combination with INCMGA00012 and Epacadostat in Patients with Advanced Breast Cancer Biotech Investing
BriaCell CEO: Incyte Collaboration Enabling New Clinical Trials for Breast Cancer Treatments CEO Interviews
Life Science Big News Roundup: Cardiol Completes Manufacturing Scale-up for Commercialization of CardiolRx(TM)100; CannaVcell Naturally Produces Cannabis’ Active Ingredients Without Growing the Plant Life Science Investing News
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
